Inventor
ROBERT B. DUBRIDGE
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
PatentTitleYear
12,528,859Single domain serum albumin binding protein202612,478,673Constrained conditionally activated binding proteins202512,128,102Constrained conditionally activated binding proteins202411,744,893Constrained conditionally activated binding proteins202311,744,892Constrained conditionally activated binding proteins202311,685,780Single domain antigen binding domains that bind human Trop2202311,623,958Single chain variable fragment CD3 binding proteins202311,607,453Mesothelin binding proteins202311,453,716Single domain serum albumin binding protein202211,406,710Constrained conditionally activated binding proteins2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (6)· patent assignee history
2022–2026Patents assigned to HARPOON THERAPEUTICS INC (4)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 6 | 2022–2025 |
| HARPOON THERAPEUTICS INC | 4 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2026 |